Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2020. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | est un(e) (attribut) | Vaccine product containing only non-live Influenza virus antigen (medicinal product) | true | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | Antigen of Influenza A virus subtype H1N1 non-live (substance) | true | Inferred relationship | Some | 1 | |
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | est un(e) (attribut) | Inf influenza A virus subtype H1N1 unspecified | true | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | Count of active ingredient | un | false | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | est un(e) (attribut) | Vaccine product containing only Influenza virus antigen in parenteral dose form | true | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | Has product characteristic | Adjuvanted vaccine product (qualifier value) | true | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | est un(e) (attribut) | Influenza A virus subtype H1N1 vaccine (product) | false | Inferred relationship | Some | ||
| Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | Influenza A virus subtype H1N1 vaccine | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | est un(e) (attribut) | True | Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
Historical name codes for vaccines reference set (foundation metadata concept)
FHIR